Modeling and simulation analysis of propyl-thiouracil (PTU), an anti-thyroid drug on thyroid peroxidase (TPO), thyroid stimulating hormone receptor (TSHR), and sodium iodide (NIS) symporter based on systems biology approach

The aim of metabolic modeling was to understand the cause effect interaction and reliance linked with the complex interactions of biological networks and molecular systems. Drugs that therapeutically modulate the biological processes of disease are often developed with limited knowledge of the underlying complexity of their specific targets. The robustness for systemic modulating behavior of thyroid hormone secretion during the course of different time unit simulation is explained in this study. In this work, a computational model has been developed which mimics the in vivo simulation. The model was constructed with the help of cell designer 4.1 used for analyzing the effect of perturbed amount of drugs at 0.1, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0 amounts as a unit, targeting Thyroid Peroxidase (TPO), Thyroid Stimulating Hormone Receptor (TSHR), and Sodium Iodide Symporter (NIS). The rate kinetic equations were defined with each reaction to simulate the molecular species dynamic behavior. The modulating behavior of thyroid hormone secretion was analyzed by the process of activation and inactivation states of TPO, TSHR, and NIS at various amounts of drugs. Obtained results explain suitably the entire observable fact of the drug effects and are capable to proceed in response to the perturbations of the natural cell. TSHR was found as the most potent molecular therapeutic target in this study.

[1]  Andreas Zell,et al.  SBMLsqueezer: A CellDesigner plug-in to generate kinetic rate equations for biochemical networks , 2008, BMC Systems Biology.

[2]  A. Taurog,et al.  A reexamination of the proposed inactivation of thyroid peroxidase in the rat thyroid by propylthiouracil. , 1989, Endocrinology.

[4]  J. Lehár,et al.  High-order combination effects and biological robustness , 2008, Molecular systems biology.

[5]  W. Yung,et al.  Secretin as a neurohypophysial factor regulating body water homeostasis , 2009, Proceedings of the National Academy of Sciences.

[6]  Eric J Kunkel,et al.  Systems biology in drug discovery. , 2006, Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference.

[7]  Sarah M. Keating,et al.  Evolving a lingua franca and associated software infrastructure for computational systems biology: the Systems Biology Markup Language (SBML) project. , 2004, Systems biology.

[8]  G. Brent Environmental exposures and autoimmune thyroid disease. , 2010, Thyroid : official journal of the American Thyroid Association.

[9]  C. Ginter,et al.  The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. , 2003, Endocrine reviews.

[10]  D. Carvalho,et al.  The importance of sodium/iodide symporter (NIS) for thyroid cancer management. , 2007, Arquivos brasileiros de endocrinologia e metabologia.

[11]  A. Weetman Autoimmune thyroid disease: propagation and progression. , 2003, European journal of endocrinology.

[12]  T. Davies,et al.  Characterization of the murine immune response to the murine TSH receptor ectodomain: induction of hypothyroidism and TSH receptor antibodies , 1998, Clinical and experimental immunology.

[13]  E. Barillot,et al.  A comprehensive modular map of molecular interactions in RB/E2F pathway , 2008, Molecular systems biology.

[14]  T. Ideker,et al.  A new approach to decoding life: systems biology. , 2001, Annual review of genomics and human genetics.

[15]  Hiroaki Kitano,et al.  The PANTHER database of protein families, subfamilies, functions and pathways , 2004, Nucleic Acids Res..

[16]  H. Kitano,et al.  Robustness trade-offs and host–microbial symbiosis in the immune system , 2006, Molecular systems biology.

[17]  J. Wilding Neuropeptides and appetite control , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[18]  H. Kitano,et al.  A comprehensive map of the toll-like receptor signaling network , 2006, Molecular systems biology.

[19]  R. Latif,et al.  New Genetic Insights from Autoimmune Thyroid Disease , 2012, Journal of thyroid research.

[20]  Véronique Giudicelli,et al.  The human anti-thyroid peroxidase autoantibody repertoire in Graves' and Hashimoto's autoimmune thyroid diseases , 2002, Immunogenetics.

[21]  M. Gershengorn,et al.  A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. , 2010, Endocrinology.

[22]  M. Gershengorn,et al.  Thyrotropin-releasing hormone receptors -- similarities and differences. , 2003, Journal of molecular endocrinology.

[23]  B. Rapoport,et al.  Thyroid peroxidase as an autoantigen. , 2007, Thyroid : official journal of the American Thyroid Association.

[24]  Ruben Abagyan,et al.  Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Mantzoros,et al.  Drug Insight: the role of leptin in human physiology and pathophysiology—emerging clinical applications , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[26]  H. Kitano,et al.  A comprehensive pathway map of epidermal growth factor receptor signaling , 2005, Molecular systems biology.

[27]  Edda Klipp,et al.  Modular rate laws for enzymatic reactions: thermodynamics, elasticities and implementation , 2010, Bioinform..

[28]  Christine Nardini,et al.  A Comprehensive Molecular Interaction Map for Rheumatoid Arthritis , 2010, PloS one.

[29]  Yang Xiang,et al.  Merging network patterns: a general framework to summarize biomedical network data , 2012, Network Modeling Analysis in Health Informatics and Bioinformatics.

[30]  G. Mugesh,et al.  Selenium Analogues of Antithyroid Drugs – Recent Developments , 2008, Chemistry & biodiversity.

[31]  Doron Levy,et al.  Modeling and simulation of the immune system as a self-regulating network. , 2009, Methods in enzymology.

[32]  B. Raaka,et al.  Human TSH receptor ligands as pharmacological probes with potential clinical application , 2009, Expert review of endocrinology & metabolism.

[33]  B. Raaka,et al.  A low-molecular-weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism. , 2008, Endocrinology.

[34]  P. Santisteban,et al.  TSH signalling and cancer. , 2007, Arquivos brasileiros de endocrinologia e metabologia.

[35]  A. Kalsbeek,et al.  Thyroid hormone effects on whole-body energy homeostasis and tissue-specific fatty acid uptake in vivo. , 2009, Endocrinology.

[36]  A. C. Ferreira,et al.  Thyroid Ca2+/NADPH-dependent H2O2 generation is partially inhibited by propylthiouracil and methimazole. , 2003, European journal of biochemistry.

[37]  P. Santisteban,et al.  A perspective view of sodium iodide symporter research and its clinical implications. , 2006, European journal of endocrinology.

[38]  L. Giudice,et al.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement. , 2009, Endocrine reviews.

[39]  Hiroaki Kitano,et al.  CellDesigner: a process diagram editor for gene-regulatory and biochemical networks , 2003 .

[40]  D. Kell Systems biology, metabolic modelling and metabolomics in drug discovery and development. , 2006, Drug discovery today.

[41]  N. Farid,et al.  Minireview: structural and functional evolution of the thyrotropin receptor. , 2004, Endocrinology.

[42]  C. Obinger,et al.  Factors influencing the study of peroxidase-generated iodine species and implications for thyroglobulin synthesis. , 2008, Thyroid : official journal of the American Thyroid Association.

[43]  B. Rapoport,et al.  A monoclonal antibody with thyrotropin (TSH) receptor inverse agonist and TSH antagonist activities binds to the receptor hinge region as well as to the leucine-rich domain. , 2009, Endocrinology.

[44]  B. Weintraub,et al.  Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. , 2002, Physiological reviews.

[45]  J. Dumont,et al.  Thyroid Hormone Synthesis and Secretion Revised , 2012 .

[46]  M. Sugawara,et al.  Dual oxidase, hydrogen peroxide and thyroid diseases , 2010, Experimental biology and medicine.

[47]  Manorama Swain,et al.  Autoimmune thyroid disorders—An update , 2008, Indian Journal of Clinical Biochemistry.

[48]  M. Mann,et al.  Phosphotyrosine interactome of the ErbB-receptor kinase family , 2005, Molecular systems biology.

[49]  E. Nillni Regulation of the hypothalamic Thyrotropin Releasing Hormone (TRH) neuron by neuronal and peripheral inputs , 2010, Frontiers in Neuroendocrinology.

[50]  N. Kikuchi,et al.  CellDesigner 3.5: A Versatile Modeling Tool for Biochemical Networks , 2008, Proceedings of the IEEE.

[51]  Samik Ghosh,et al.  A comprehensive molecular interaction map of the budding yeast cell cycle , 2010, Molecular systems biology.

[52]  E. Klipp,et al.  Mathematical modeling of intracellular signaling pathways , 2006, BMC Neuroscience.

[53]  P. Carayon,et al.  Structural and functional aspects of thyroid peroxidase. , 2006, Archives of biochemistry and biophysics.

[54]  B. Rapoport,et al.  Autoimmune Response to the Thyroid in Humans: Thyroid Peroxidase-The Common Autoantigenic Denominator , 2000, International reviews of immunology.

[55]  Krishna Misra,et al.  Metabolic Modeling and Simulation Analysis of Thyroid Disorder Pathway , 2012 .

[56]  Yukiko Matsuoka,et al.  Integration of CellDesigner and SABIO-RK , 2007, Silico Biol..

[57]  Manish Kumar Gupta,et al.  Comparative docking and ADMET study of some curcumin derivatives and herbal congeners targeting β-amyloid , 2012, Network Modeling Analysis in Health Informatics and Bioinformatics.

[58]  Hiroaki Kitano,et al.  A graphical notation for biochemical networks , 2003 .

[59]  H. Kitano,et al.  A comprehensive map of the mTOR signaling network , 2010, Molecular systems biology.

[60]  A. Hollenberg The role of the thyrotropin-releasing hormone (TRH) neuron as a metabolic sensor. , 2008, Thyroid : official journal of the American Thyroid Association.

[61]  Giovanni Colonna,et al.  Modeling of the Bacterial Mechanism of Methicillin-Resistance by a Systems Biology Approach , 2009, PloS one.

[62]  Alberto Policriti,et al.  Studying cancer-cell populations by programmable models of networks , 2012, Network Modeling Analysis in Health Informatics and Bioinformatics.